References
- 1. Fodor R, Grigorescu B, veres M, et al. Plasma neutrophil Gelatinase Associated Lipocalin (NGAL) - Early Biomarker for Acute Kidney Injury in Critically Ill Patients. J Crit Care Med. 2015;4:154-61.
- 2. Fuernau G, Poenisch C, Eitel I, et al. Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: A biomarker substudy of the IABP-SHOCK II-trial. Int J Cardiol. 2015;191:159-66.
- 3. Torregrosa I, Montoliu C, Urios A, et al. Urinary KIM-1, NGAL and L-FABP for the diagnosis of AKI in patients with acute coronary syndrome or heart failure undergoing coronary angiography. Heart Vessels. 2015;30:703-11.
- 4. Lindberg S, Pedersen SH, Mogelvang R, et al. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with STsegment elevation myocardial infarction treated with primary percutaneous coronaryintervention. J Am Coll Cardiol. 2012;60:339-45.
- 5. Hemdahl AL, Gabrielsen A, Zhu C, et al. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler Thromb Vasc Biol. 2006;26:136-42.
Language: English
Page range: 56 - 57
Submitted on: Dec 12, 2015
Accepted on: Dec 16, 2015
Published online: Feb 9, 2016
Published in print: Jan 1, 2016
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2016 Ota Hlinomaz, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.